MAXIBAN PREMIX DIN 01902687
Status: Marketed
Holder: ELANCO CANADA LIMITED
Available to quote
Health Canada record
| Active ingredient(s) | NARASIN 80 G; NICARBAZIN 80 G |
|---|
| Dosage form | Drug Premix |
|---|
| Route | Oral |
|---|
| Schedule | NON-PRESCRIPTION DRUGS |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1991 |
|---|
| Current status date | 16-May-2018 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2026-09-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NARASIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02431696 | MONTEBAN 100 | ELANCO CANADA LIMITED | Drug Premix | NARASIN 100 G | Marketed |
| 00707538 | MONTEBAN 70 | ELANCO CANADA LIMITED | Drug Premix | NARASIN 70 G | Dormant |
| 02010038 | PREMELANGE 25/2 GRIL MEDICAMENTE (MONTEBAN) | LA COOP FEDEREE | Drug Premix | NARASIN 5.6 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 20049 | 2017-11-10 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 18417 | 2016-08-31 | Supplement to a New Drug Submission (SNDS) | ADDITION OF DOSE RANGE |
| 15118 | 2014-01-14 | Supplement to a New Drug Submission (SNDS) | CHANGE IN WITHDRAWL PERIOD |
Request a quote for MAXIBAN PREMIX
How to read a Canadian DIN record